» Articles » PMID: 33564358

Retrospective Study of Characteristics and Management of Pyogenic Liver Abscess During 5 Years' Experience

Overview
Specialty Pathology
Date 2021 Feb 10
PMID 33564358
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Pyogenic liver abscess is a life-threatening disease. It is urgent to review the clinical patterns, risk factors, and management of the disease in order to improve the outcome. We retrospectively analyzed 70 cases of pyogenic liver abscess diagnosed and treated at Shanghai Ninth People's Hospital over five years, including the clinical features, management, and outcome. The average age was 63.06 ± 12.33 y. 71.4% (50/70) were males. 85.7% (60/70) patients presented with fever. The major abnormalities in laboratory were increased CRP and liver dysfunction. 77.8% (14/18) pus cultures came with positive reports, while 26.5% (9/34) blood cultures were positive. was the predominant pathogen both in blood (66.7%, 6/9) and pus (64.3%, 9/14) cultures. 42.9% (30/70) patients also had diabetes. Patients with diabetes presented with significantly larger size of abscess ( = 0.014) and were more susceptible to infection ( = 0.002). We revealed HbA1c ( = 0.047), accompanying malignancy ( = 0.030), and septic shock ( = 0.045) were three independent risk factors for PLA. In conclusion: pyrogenic liver abscess was atypical; microbiologic positivity of pus culture was higher than that of blood culture; was the predominant pathogen in pyrogenic liver abscesses, especially in patients with diabetes; and patients with hyperglycemia had poor outcome.

Citing Articles

Clinical manifestations, diagnosis, treatment, and outcome of pyogenic liver abscess: a retrospective study.

Wang H, Xue X J Int Med Res. 2023; 51(6):3000605231180053.

PMID: 37345580 PMC: 10291412. DOI: 10.1177/03000605231180053.


Clinical efficacy of ulinastatin in the treatment of unliquefied pyogenic liver abscess complicated by septic shock: A randomized controlled trial.

Guo M, Zhou B Immun Inflamm Dis. 2023; 11(4):e822.

PMID: 37102655 PMC: 10108682. DOI: 10.1002/iid3.822.

References
1.
Lee K, Wong S, SHEEN P . Pyogenic liver abscess: an audit of 10 years' experience and analysis of risk factors. Dig Surg. 2002; 18(6):459-65; discussion 465-6. DOI: 10.1159/000050194. View

2.
Kubo H, Taniguchi F, Shimomura K, Nanishi K, Ueshima Y, Takahashi A . Inferior vena caval thrombosis complicating pyogenic liver abscess after pancreatoduodenectomy: a case report. Surg Case Rep. 2015; 1(1):77. PMC: 4562987. DOI: 10.1186/s40792-015-0080-y. View

3.
Liu L, Li F, Xu L, Wang J, Li M, Yuan J . Cyclic AMP-CRP Modulates the Cell Morphology of in High-Glucose Environment. Front Microbiol. 2020; 10:2984. PMC: 6985210. DOI: 10.3389/fmicb.2019.02984. View

4.
Tan T, Ong M, Cheng Y, Ng L . Hypermucoviscosity, rmpA, and aerobactin are associated with community-acquired Klebsiella pneumoniae bacteremic isolates causing liver abscess in Singapore. J Microbiol Immunol Infect. 2017; 52(1):30-34. DOI: 10.1016/j.jmii.2017.07.003. View

5.
Lee C, Chen I, Chuah S, Tai W, Chang C, Chen F . Impact of glycemic control on capsular polysaccharide biosynthesis and opsonophagocytosis of Klebsiella pneumoniae: Implications for invasive syndrome in patients with diabetes mellitus. Virulence. 2016; 7(7):770-8. PMC: 5029304. DOI: 10.1080/21505594.2016.1186315. View